Price Range (₹)
Issue Size (₹ in Cr.)
Minimum Quantity
Bidding Period
| Shareholder | |
| Retail Individual Investor | |
| Non-Institutional Investor | |
| Qualified Institutional Buyers | |
| Employee | |
| Overall |
- The company engages in developing,manufacturing and marketing a wide range of formulations including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
- Were the 7th largest in the Indian pharmaceutical market(IPM) by domestic sales for the six months ended September 30,2021 (Source: IQVIA Dataset and Company DRHP)
One of the leading and fast growing companies with significant presence in the IPM
Outperformed the IPM with domestic sales growth at a CAGR of 15.3% from fiscal 2011 to fiscal 2021, compared to 10.8% sales growth of the IPM in the same period (Source:IQVIA Dataset, Company DRHP)
Proven track record of building brands
Demonstrated capabilities in building brands and had a portfolio of 595 brands in IPM between fiscal 2017 and fiscal 2021 (Source: Company DRHP)
Diversified presence across global markets with calibrated business model
The company operations are diverse in terms of geography, product portfolio, and business model, with revenue form operations outside India representing 48.27% and 36.07% of total revenue from opeations, in Fiscal 2021 and the six months ended september 30,2021,respectively. Distributes products across more than 170 countries through differentiated business models for each key markets. (Source: Company DRHP)
The company may experience a shortfall in the supply of raw materials or an increase in their prices, or of other input costs.
The raw materials used in the manufacture of products, including packaging materials, are subject to supply disruptions and price volatility caused by various factors, such as commodity market fluctuations, the quality and availiability of such materials, currency fluctuations, consumer demand, and the regulatory environment. (Source: Company DRHP)
The company could experience a material slowdown or shutdown in manufacturing or R&D operations
Business is dependent on its ability to manage manufacturing and R&D facilities, which are subject to various operating risks and factors outside control including breakdown and/or failure of equipment or industrial accidents, severe weather conditions, natural disasters etc.(Source: Company DRHP)
-Overview of Indian Pharmaceutical Market(IPM) : The size of IPM has increased from ₹ 483 billion in fiscal 2011 to ₹ 1343 billion in fiscal 2021 at ~11% CAGR over fiscal 2011-21. The IPM is forecast to grow at a CAGR of 10-11% to reach ₹2150-226 billion by fiscal 2026.(Source IQVIA SSA)
For ICICI Bank linked A/c
For non ICICI Bank A/c
Go to the IPO section, select the IPO you want to apply from the list and click on ‘Apply’.
Fill in the quantity of the number of shares you want to buy. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Click on proceed to confirm the order. You can view the placed order under “order book”.
Choose the IPO you want to apply from the list. Click on Apply.
Fill in the quantity of shares. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Check the A/C, UPI details and click on proceed. You will get an UPI link by which payment can be made.
Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Top Mutual Funds
